Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
Clinical trial NCT07386704 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07386704
- Sponsor
- Peking University First Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-09
- Primary completion
- 2026-12-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.